In the present study, we assessed whether elevated ( 15 mmHg) PCWP (pulmonary capillary wedge pressure) can be detected using the blood pressure response to the Valsalva manoeuvre in a group of elderly patients with various cardiac disorders, including atrial fibrillation and valvular heart disease, and healthy elderly controls. The Valsalva manoeuvre was performed in 93 patients (71 + − 4 years) and 28 healthy controls (70 + − 4 years) undergoing right-sided cardiac catheterization. Blood pressure was measured non-invasively with Finapres. PPR (pulse pressure ratio), the ratio of minimum pulse pressure during phase 2 and maximum pulse pressure during phase 1 of the Valsalva manoeuvre, was correlated with PCWP (r = 0.63, P < 0.001). The area under the receiver operator characteristic curve of PPR with elevated PCWP was 0.85 (P < 0.001). For PPR = 0.62, sensitivity for elevated PCWP was 80 %, specificity was 79 %, positive predictive value was 76 % and negative predictive value was 83 %. Correlation of PPR with PCWP and the ability of PPR to detect elevated PCWP was present in atrial fibrillation, heart failure and valvular heart disease. In conclusion, PPR is a sensitive and specific instrument to diagnose elevated PCWP non-invasively in a large group of elderly patients with various cardiac disorders. This makes the Valsalva manoeuvre a useful non-invasive tool for diagnosing heart failure, applicable in elderly patients with common cardiac disorders, such as atrial fibrillation and valvular heart disease.
INTRODUCTION
The prognosis of heart failure can be improved with early diagnosis and treatment [1] . However, physical examination and radiographical methods are not very sensitive for detection of heart failure, and heart failure can be missed easily, especially in the elderly [2, 3] . Therefore a simple non-invasive bedside technique for diagnosis of heart failure could be useful.
Heart failure can be defined as the pathophysiological state in which the heart is unable to pump blood at a rate needed by the metabolizing tissues or can do so only from elevated filling pressure [4] . Since the BP (blood pressure) response to the Valsalva manoeuvre is related to PCWP (pulmonary capillary wedge pressure), which is a measure of left ventricular filling pressure, it may be used to diagnose heart failure. An abnormal BP response to the Valsalva manoeuvre in the presence of heart failure was reported over six decades ago [5] . From 1989, reports have quantitatively described the relationship between the BP response to the Valsalva manoeuvre and cardiac filling pressures [6] [7] [8] [9] [10] . These reports all described small numbers of patients, with only a few patients with valvular heart disease being reported, and only two patients were reported to have atrial fibrillation [7] . Furthermore, these studies were not restricted to the elderly in whom the prevalence of heart failure is highest [3] .
Valvular heart disease and arrhythmias are often present in the elderly and can lead to heart failure or worsening of heart failure [3] . A method to diagnose heart failure should not only be applicable in the elderly, but should also be applicable in common cardiac disorders, such as atrial fibrillation and valvular heart disease. Therefore the present study sought to assess whether elevated PCWP ( 15 mmHg) can be detected in a large heterogeneous group of elderly patients with various cardiac disorders, including atrial fibrillation and valvular heart disease, and healthy elderly controls.
MATERIALS AND METHODS

Patients
Between March 2000 and April 2002, consecutive elderly patients (n = 104), aged 65 years and older, who were scheduled to undergo right-sided cardiac catheterization at the Catheterization Laboratory or the Coronary Care Unit at the University Medical Center, Nijmegen, The Netherlands, were evaluated to take part in the present study. The indication for catheterization was determined by the treating physician at the outpatient clinic or during hospitalization, and was not performed for research purposes. Reasons for hospital admission were congestive heart failure or acute coronary syndrome. Reasons for right-sided catheterization (either with or without leftsided cardiac catheterization) were diverse, including as part of the preparation for surgery for valvular heart disease and/or coronary artery bypass grafting, as part of the diagnostic process for the cause of heart failure, and for haemodynamic monitoring of patients with acute heart failure.
Severe chronic obstructive lung disease has a marked influence on the BP response to the Valsalva manoeuvre [11] and was a reason for exclusion. Baseline characteristics were recorded from the patient's medical file at the time of catheterization. Echocardiography or nuclear cardiac imaging, before or after catheterization, was performed at the discretion of the treating physician and was not part of the study protocol. All subjects gave written informed consent. The study was approved by the Ethics Committee for Research on Human Subjects of the University Medical Center, Nijmegen, The Netherlands, and conformed to the principles outlined in the Declaration of Helsinki [12] .
Controls
Data were used from 28 healthy elderly subjects, aged 70 + − 4 years, who participated in a study on normal values of the BP response to the Valsalva manoeuvre and PCWP, which was published recently [13] . The recruitment of these subjects was described previously [14] . In brief, this study [14] described that it was possible to recruit healthy elderly volunteers for cardiovascular research, which included cardiac catheterization, and that the main motive for participation was the cardiovascular screening prior to inclusion in the actual study.
Materials
Measurement devices were connected to a personal computer through a data-acquisition box and an AD converter. Signals were recorded and sampled with the MID TestOrganizer for Windows 95 version 5.3 (Department of Biomedical Engineering, University Medical Center, Nijmegen, The Netherlands). The entire measurement system was placed on a mobile handcart, which enabled easy bedside monitoring.
Right-sided cardiac catheterization
PCWP and PAP (pulmonary artery pressure) were determined by right-sided catheterization using a 7 French Swan Ganz catheter (Baxter). PCWP and PAP were measured with the zero level fixed at the intersection of the fourth intercostal space and the mid-axillary line and were measured at the end of expiration. In cases where coronary angiography or ventriculography were planned, pressure measurements were performed before administration of contrast medium.
Measurement of BP and heart rate
Non-invasive continuous arterial BP and heart rate were measured beat-to-beat using a Finapres device (Ohmeda 2300) on the index or middle finger. Finapres has been reported to be an accurate method of assessing BP noninvasively [15] and for assessing BP changes during the Valsalva manoeuvre [16] .
Finapres BP was analysed offline with the software program BeatScope, version1.0 (TNO-TPD Biomedical Instrumentation), which computes aortic flow from pressure in humans, using a non-linear three-element model. This model represents aortic characteristic impedance, arterial compliance and systemic vascular resistance [17] . Although Modelflow does not supply reliable absolute cardiac output values in the elderly without invasive calibration [18] , Modelflow has been reported to be suitable for assessing relative changes in cardiac output [19] . The lower registration is the expiratory pressure during the Valsalva manoeuvre. An abnormal BP response, which is seen in heart failure, is characterized by absence of decrease in BP during phase 2, as shown in the lower panel.
The Valsalva manoeuvre
The Valsalva manoeuvre consisted of a normal inspiration followed by forced expiration for 15 s with the aim of reaching a pressure of 40 mmHg in a tube which was connected to a disposable pressure transducer (Baxter). A tiny hole in the tube ensured that the pressure was generated in the thorax and not in the mouth by closing the glottis.
A normal BP response to the Valsalva manoeuvre consists of four typical phases, as shown in the upper panel of Figure 1 . Phase 1 represents an initial rise in arterial pressure, caused by transmission of the increased intrathoracic pressure to the peripheral arteries; phase 2 is characterized by reduction of systolic, diastolic and pulse pressure, accompanied by a reflex increase in heart rate, caused by reduction of venous return; phase 3 begins with release of the strain when arterial pressure falls suddenly due to the fall of intra-thoracic pressure; and phase 4 is characterized by an overshoot of arterial pressure to above control levels accompanied with reflex bradycardia.
An abnormal BP response, which is seen in heart failure, is characterized by the absence of a decrease in BP during phase 2, as shown in the lower panel of Figure 1 . The absence of a decrease in BP during phase 2 is caused by elevation of central venous and pulmonary venous pressure, which enables filling of the heart in spite of the increase in intra-thoracic pressure [5, 20] . The decrease in BP was also reported to depend on the slope and the position on the left-ventricular function curve [20] . On this curve, stroke work, of which pulse pressure and mean arterial pressure are approximate indices, is plotted against filling pressure. With high filling pressures, at the flattened part of the curve, a fall in filling pressure will affect stroke work only minimally. The slope of the curve is dependent on the severity of the heart disease. In patients with elevated left ventricular filling pressures, a decrease in filling pressure due to straining will not result in a decrease in arterial BP.
Before catheterization, the Valsalva manoeuvre was practiced to make the patient familiar with the manoeuvre. Immediately after measurement of PCWP and PAP, the Valsalva manoeuvre was performed in the supine position, preferably three times but at least once, depending on the patient's ability. Between two successive manoeuvres, a 2-min rest period was applied. The expiratory pressure was displayed for the subject via a small monitor for biofeedback. The patient was encouraged to achieve an expiratory pressure of 40 mmHg or, if not possible, as high as possible, for at least 12 s. A minimum cut-off level of expiratory pressure of 20 mmHg was chosen, since this level still induces a significant decrease in pulse pressure in normal subjects [21] .
Valsalva ratios
Valsalva ratios were calculated from the BP response to the Valsalva manoeuvre. PPR (pulse pressure ratio) was calculated as the ratio of the mean of the three lowest successive pulse pressures in phase 2 and the mean of the highest three successive pulse pressures in phase 1 (A/B; see Figure 1 ). In atrial fibrillation, the mean of the five lowest successive pulse pressures in phase 2 and the mean of the five highest successive pulse pressures in phase 1 were used. The systolic BP ratio, the diastolic BP ratio and stroke volume ratio were calculated in the same way. The heart rate ratio was the ratio of the highest heart rate, calculated as the inverse of the mean of the three successive shortest inter-beat intervals during phase 2, and the lowest heart rate, the inverse of the mean of the three successive longest inter-beat intervals during phase 1. For all ratios, the mean of the Valsalva manoeuvres performed by a single patient was used for further analysis.
Data analysis and statistics
Statistical analysis was performed with SPSS 10.0 for Windows. Values are means + − S.D. A two-sided P-value 0.05 was considered to indicate statistical significance. Variability in parameters during the different Valsalva manoeuvres was expressed as the within-subject S.D., calculated as the square root of the mean variance of a variable during three Valsalva manoeuvres. The CV (coefficient of variation) was the within-subject S.D. expressed 
as percentage of the group mean [22] . Linear regression modelling was used to estimate the univariate and multivariate relationship of the BP response to the Valsalva manoeuvre with PCWP. Stepwise forward selection was performed with a value of P < 0.05 as the criterion to remain in the model. Assessment of the discriminatory power of the BP response to the Valsalva manoeuvre to detect elevated PCWP ( 15 mmHg) was performed with ROC (receiver operator characteristic) analysis. χ 2 or Fischer's exact tests were used for dichotomous data, and Mantel-Haenszel χ 2 tests for ordinal data. For comparison of continuous data, independent samples Student t tests were used.
RESULTS
Characteristics of the patients
During the study period, 104 patients undergoing rightsided catheterization were initially included in the study. The data from five patients were discarded because we were not able to get a stable Finapres signal (n = 4), and one patient developed non-sustained ventricular tachycardia during the Valsalva manoeuvre, caused by the Swan-Ganz catheter or by the Valsalva manoeuvre itself. Of the remaining 99 patients, six (five female and one male) were not able to achieve an expiratory pressure of at least 20 mmHg and thus their data were excluded from analysis.
The baseline characteristics of the remaining 93 patients are shown in Table 1 . LVEF (left ventricular ejection fraction) data were available in all patients. In 87 patients, LVEF was assessed by echocardiography. Of Of the 28 controls, six were females. None of the controls used any medication. All controls performed three Valsalva manoeuvres. The CVs of the systolic BP ratio, diastolic BP ratio, PPR, stroke volume ratio and of the heart rate ratio were 9 %, 9 %, 14 %, 13 % and 9 % respectively.
Haemodynamic data of the catheterization and Valsalva ratios of the patients and controls are shown in Table 2 .
Correlation between the BP response to the Valsalva manoeuvre and PCWP
In the patients, PPR was significantly correlated with PCWP (r = 0.62, P < 0.001), as were systolic BP ratio (r = 0.54, P < 0.001), diastolic BP ratio (r = 0.35, P = 0.001) and stroke volume ratio (r = 0.58, P < 0.001). The heart rate ratio was not correlated with PCWP. Using stepwise forward analysis with systolic BP ratio, PPR, diastolic BP ratio and stroke volume ratio, PPR was related most strongly to PCWP. Therefore only PPR was used in further regression modelling. Figure 2 shows a scatter plot of PCWP and PPR and the regression lines of PCWP with PPR in patients, controls and patients and controls together. In the group of patients and controls together, the correlation coefficient of PPR and PCWP was 0.63 (P < 0.001).
The discriminatory power of the BP response to the Valsalva manoeuvre to detect elevated ( 15 mmHg) PCWP in patients and controls was performed by plotting an ROC curve (Figure 3 ). The AUC (area under the ROC curve) was 0.85 [95 % CI (confidence interval), 0.78-0.92; P < 0.001]. For a cut-off value of PPR of 0.62, the sensitivity for elevated PCWP was 80 %, specificity was 79 %, positive predictive value was 76 % and negative predictive value was 83 %.
Influence of cardiac disorders and use of medication
Of the baseline variables, heart failure (in medical history or as the reason for hospital admission), presence of pulmonary rales and mitral stenosis were significantly related to PCWP. Stepwise regression modelling identified PPR as the strongest predictor of PCWP, with heart failure and mitral stenosis as other independent predictors of PCWP.
In Table 3 , patients were grouped by the presence or absence of various cardiac disorders. If patients with atrial fibrillation are excluded from analysis, the correlation coefficient remained unchanged in the remaining patients. In patients with atrial fibrillation (n = 16), the correlation coefficient was significant. The AUC for diagnosis of The AUC is 0.85 (95 % CI, 0.78-0.92; P < 0.001). The cut-off value of PPR of 0.62. elevated PCWP was approx. 0.80 in all subgroups. For the small group of patients with mitral valve stenosis (n = 6), PCWP was elevated and PPR was 0.6 in all patients.
In Table 4 , patients were grouped according to the use of β-blockers, ACE-inhibitors, calcium channel blockers, digoxin and diuretics. The correlation between the PPR and PCWP was significant in all subgroups, and the AUC for diagnosis of elevated PCWP was > 0.80 in all subgroups.
Influence of expiratory pressure
Of the 93 patients, nine (10 %) were able to achieve an expiratory pressure during the Valsalva manoeuvre of 40 mmHg; however, 68 patients (73 %) were able to achieve 30 mmHg. The expiratory pressure was not significantly correlated with PCWP (r = 0.14); however, it was correlated with PPR (r = 0.39, P < 0.001). The higher the expiratory pressure achieved, the higher the correlation coefficient of PCWP with PPR. Of the patients unable to achieve an expiratory pressure of 30 mmHg, more patients were: (i) female, (ii) of shorter height, (iii) on less β-blockers and (iv) in higher NYHA (New York Heart Association) classes compared with those who were able to achieve 30 mmHg. All controls were able to achieve an expiratory pressure of at least 30 mmHg.
Relationship between PPR and other measures of cardiac filling pressure in patients
PPR was correlated with right atrial pressure (r = 0.34, P = 0.001; n = 88), diastolic PAP (r = 0.49, P < 0.001; 
Correlation between echocardiographic variables and PCWP
Echocardiography was not performed as part of the study protocol, but data, although not complete, were available in 87 patients (Table 5) . Data were used from echocardiography performed before or after the study. Mean duration between echocardiography and the study in patients was 138 + − 250 days, ranging between 1480 days before and 312 days after the study; 90 % of all echocardiography studies was performed between 356 days before and 4 days after the Valsalva study. Of the available data, only E (peak velocity early diastolic rapid filling wave; r = 0.29, P = 0.022) and the E/A ratio (where A is the peak velocity late diastolic atrial contraction wave; r = 0.29, P = 0.043) correlated with PCWP. LVEF, A, DT (E velocity deceleration time), and PV S and PV D (pulmonary vein peak systolic and diastolic velocity respectively) did not correlate with PCWP.
DISCUSSION
The main finding in the present study is that the BP response to the Valsalva manoeuvre, in terms of PPR, is a reasonably accurate method of predicting elevated PCWP in a heterogeneous group of elderly patients with various cardiac disorders. The diagnostic feature of PPR in predicting elevated PCWP is not influenced by the presence or absence of various common cardiac disorders. This makes the BP response to the Valsalva manoeuvre a non-invasive tool for diagnosis of heart failure, applicable in elderly patients with various cardiac disorders, such as atrial fibrillation and valvular heart disease. In most of the reports describing the relationship between the BP response to the Valsalva manoeuvre and cardiac filling pressures, patients with arrhythmias were excluded [8, 10] , and only two patients were reported to have atrial fibrillation [7] . In the general population, the prevalence of atrial fibrillation in the elderly is approx. 6 % [23] . In heart failure patients, the prevalence varies from 10 % in NYHA class II to 50 % in NYHA class IV [23] . The exclusion of patients with atrial fibrillation would therefore be a serious limitation of a tool for diagnosing heart failure. In the present study, we were able to assess PCWP in patients with atrial fibrillation using the BP response to the Valsalva manoeuvre.
In studies on the quantitative relationship of the BP response to the Valsalva manoeuvre, only 11 patients were reported to suffer from cardiac valve abnormalities. In our present study, 58 patients (62 %) had some kind of valvular heart disease. The discriminatory power of the BP response to the Valsalva manoeuvre to detect elevated PCWP in patients with valvular heart disease was high. In the elderly population, the prevalence of valvular heart disease is high; in randomly selected subjects from 55-86 years old, the prevalence of severe aortic valve calcification was reported to be 13 %, and (mild) aortic regurgitation was 29 % [24] . Therefore the results of the present study are essential, especially since previous data in elderly patients suffering from common cardiac disorders are scarce.
Importantly, the discriminatory power of PPR to detect elevated PCWP was present in all subgroups of patients grouped by the use of medication. This is an important finding as many elderly cardiac patients use one or more cardiovascular drugs, which makes this method applicable in elderly patients with multiple drug therapy.
Although PPR correlated significantly with PCWP, the correlation was moderate, which impedes exact assessment of PCWP. The correlation of the BP response with PCWP is in accordance with one report [6] , but is less strong than in other reports [7, 10] . Several mechanisms could account for this. First, many of our elderly patients were not able to achieve an expiratory pressure of 40 mmHg during the Valsalva manoeuvre. Therefore the expiratory pressures achieved by our patients deviated between 20 and 40 mmHg, which must have influenced our results. It became clear that the higher the expiratory pressure the stronger the correlation between PPR and PCWP. However, in particular, small females in a high NYHA class were not able to achieve the expiratory pressure. In future studies, this should be accounted for. Secondly, the method used for continuous BP measurement could have played a role. We used Finapres instead of the Vericor system, which was used in a study reporting a strong correlation between the BP response and PCWP [7] . On the other hand, Finapres was also used in a study reporting a stronger correlation than we found [10] , and a study reporting a similar correlation used intraaortal BP measurement with fluid-filled catheters [6] . Thirdly, we assessed PCWP with fluid-filled catheters, which are not as reliable as high-fidelity catheters. Interestingly, in one study [9] , PPR, which was derived from intra-aortal BP using high-fidelity catheters, had no significant relationship with LVEDP. However, this study [9] was performed solely in patients with preserved left ventricular function and relatively low cardiac filling pressures. Finally, with increasing age, variability of biological parameters increases [25] , which might explain the less strong correlation of the BP response with the Valsalva manoeuvre and PCWP.
Serious doubts concerning the safety of the Valsalva manoeuvre have been reported because of a supposed accompanying fall in coronary blood flow [26] . On the other hand, the Valsalva manoeuvre was reported as a non-pharmacological method to relieve angina pectoris, suggesting that the Valsalva manoeuvre reduces cardiac oxygen demand, relieving acute ischaemia rather than aggravating it [27] . In more than 2100 patients with severe heart disease, no complications were observed during carefully monitored Valsalva manoeuvres [7] . In the present study, a broad-complex tachycardia occurred during the Valsalva manoeuvre in one patient, probably caused by mechanical irritation by the Swan-Ganz catheter during the manoeuvre. Therefore we conclude that the Valsalva manoeuvre can be used safely in elderly cardiac patients.
Although echocardiography was not performed for research purposes in our present study, echocardiographic data were available in most patients. However, echocardiography and catheterization were not performed on the same day. Regrettably, most of the echocardiographic studies were incomplete and tissue Doppler imaging data were not available. As expected, E and the E/A ratio correlated with PCWP, but not as strongly as the PPR and PCWP. The limited correlation between echocardiographic parameters and PCWP might be related to the wide time lag between echocardiography and performance of the Valsalva manoeuvre. We acknowledge that echocardiography is the method for assessment of cardiac function and is an important tool in the diagnosis of heart failure [3] ; however, cardiac dysfunction and heart failure are not synonymous. Based on the definition of heart failure as the state in which the heart is unable to pump blood at the rate needed by the metabolizing tissues or can do so only with elevated filling pressures [4] , assessment of left ventricular filling pressure or PCWP seems mandatory. Several echocardiographic approaches to assess PCWP have been proposed, but it is not clear if any of these methods provides the precision and accuracy needed for the evaluation of patients [28] . A correlation coefficient between PCWP and early transmittal velocity/tissue Doppler mitral annular early diastolic velocity of 0.69 has been reported in a study by Dokainish et al. [29] , which, notably, excluded patients with atrial fibrillation, mitral valvular disease or unstable angina. We cannot conclude that the Valsalva ratios are superior to echocardiography or vice versa. Whether the Valsalva manoeuvre may give information additional to echocardiography will need to be assessed in further studies.
We did not measure natriuretic peptides in our present study patients. Natriuretic peptides have been reported to be promising in the diagnosis of heart failure, which was confirmed by independent cardiologists based on clinical symptoms [30] . However, the correlation between PCWP and natriuretic peptides has been reported to be poor [29] , as was the diagnostic accuracy to detect elevated PCWP [31] . Although the AUC of PPR for elevated PCWP was high (> 0.80) in our present study, one has to bear in mind that this still means that, with a cut-off value of 0.62, a sensitivity of 80 % and specificity of 79 %, 12 % of the subjects will be diagnosed incorrectly as having elevated PCWP and 9 % will be diagnosed incorrectly as having a normal PCWP. However, PPR in our present study performed better than BNP (B-type natriuretic peptide) did in the study by Dokainish et al. [29] (a sensitivity of 91 % and a specificity of 56 %), but slightly worse than echocardiographic early transmitral velocity/tissue Doppler mitral annular early diastolic velocity (sensitivity of 85 % and specificity of 88 %) [29] . Therefore further studies on the detection of elevated PCWP should be performed, combining and comparing the BP response to the Valsalva manoeuvre, natriuretic peptides and echocardiography.
Limitations
The decrease in pulse pressure is related to expiratory pressure [21] , meaning that, if the expiratory pressure is low, the decrease in pulse pressure is small regardless of cardiac filling pressure or cardiac function. In our group of elderly subjects, the maximum expiratory pressure during the Valsalva manoeuvre differed among subjects and not all subjects were able to achieve an expiratory pressure of 40 mmHg. This might have attenuated the correlation between the PPR and PCWP. The difficulty to achieve a preset expiratory pressure may be a serious limitation of the assessment of PCWP by the BP response to the Valsalva manoeuvre.
Conclusions
The BP response to the Valsalva manoeuvre, in terms of PPR, is a reasonably accurate method to predict elevated PCWP in a group of elderly patients with various cardiac disorders and healthy elderly controls. The diagnostic feature of PPR in predicting elevated PCWP is not influenced by the presence or absence of various common cardiac disorders or by cardiovascular drug therapy. This makes the BP response to the Valsalva manoeuvre a useful non-invasive tool for diagnosis of heart failure, which is applicable in elderly patients with common cardiac disorders, such atrial fibrillation and valvular heart disease.
